JP2013075894A5 - - Google Patents

Download PDF

Info

Publication number
JP2013075894A5
JP2013075894A5 JP2012202153A JP2012202153A JP2013075894A5 JP 2013075894 A5 JP2013075894 A5 JP 2013075894A5 JP 2012202153 A JP2012202153 A JP 2012202153A JP 2012202153 A JP2012202153 A JP 2012202153A JP 2013075894 A5 JP2013075894 A5 JP 2013075894A5
Authority
JP
Japan
Prior art keywords
group
optionally substituted
substituted
saturated heterocyclic
represented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012202153A
Other languages
English (en)
Japanese (ja)
Other versions
JP5715605B2 (ja
JP2013075894A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2012202153A priority Critical patent/JP5715605B2/ja
Priority claimed from JP2012202153A external-priority patent/JP5715605B2/ja
Publication of JP2013075894A publication Critical patent/JP2013075894A/ja
Publication of JP2013075894A5 publication Critical patent/JP2013075894A5/ja
Application granted granted Critical
Publication of JP5715605B2 publication Critical patent/JP5715605B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012202153A 2011-09-14 2012-09-14 Ｎ−アシル環状アミン誘導体またはその医薬上許容される塩からなる医薬 Expired - Fee Related JP5715605B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2012202153A JP5715605B2 (ja) 2011-09-14 2012-09-14 Ｎ−アシル環状アミン誘導体またはその医薬上許容される塩からなる医薬

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2011200374 2011-09-14
JP2011200374 2011-09-14
JP2012202153A JP5715605B2 (ja) 2011-09-14 2012-09-14 Ｎ−アシル環状アミン誘導体またはその医薬上許容される塩からなる医薬

Publications (3)

Publication Number Publication Date
JP2013075894A JP2013075894A (ja) 2013-04-25
JP2013075894A5 true JP2013075894A5 (enExample) 2014-03-13
JP5715605B2 JP5715605B2 (ja) 2015-05-07

Family

ID=48479653

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012202153A Expired - Fee Related JP5715605B2 (ja) 2011-09-14 2012-09-14 Ｎ−アシル環状アミン誘導体またはその医薬上許容される塩からなる医薬

Country Status (1)

Country Link
JP (1) JP5715605B2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000032987A (ja) * 1998-07-16 2000-02-02 Dai Ichi Seiyaku Co Ltd Ｄｎａ
CN104140421B (zh) * 2013-05-08 2017-04-05 上海医药工业研究院 苯并异噻唑类化合物及在制备抗精神分裂症药物中的应用
CN105315267B (zh) * 2014-07-30 2019-06-04 江苏恩华药业股份有限公司 一种酰胺类衍生物及其应用
JP2019059672A (ja) * 2015-12-28 2019-04-18 大日本住友製薬株式会社 治療抵抗性うつ病等の治療薬

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133061A (en) * 1962-11-13 1964-05-12 Sterling Drug Inc Piperidine carboxamides and derivatives thereof
FR2285883A1 (fr) * 1974-09-30 1976-04-23 Cerm Cent Europ Rech Mauvernay Nouveaux composes chimiques a activite bronchospasmolytique et antitussive, et procede pour leur obtention
WO1994007496A1 (en) * 1992-10-07 1994-04-14 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists
NZ533358A (en) * 2001-12-19 2007-05-31 Lundbeck & Co As H 3,4-Dihydro-1H-isoquinolin-2-yl-derivatives for use as NK2 receptor antagonists
CA2551346A1 (en) * 2003-12-31 2005-07-21 Warner-Lambert Company Llc N-substituted piperidine and piperazine derivatives

Similar Documents

Publication Publication Date Title
ES2923875T3 (es) Moduladores de la vía integrada del estrés
JP2018527295A5 (enExample)
CA3183081A1 (en) Combination therapy for treatment of cancer
JP2016530262A5 (enExample)
AR075729A1 (es) Derivados de benzofuranilo, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de la obesidad y/o diabetes.
IN2012DN02968A (enExample)
FI3406609T3 (fi) Bisyklisiä atsayhdisteitä muskariinireseptorin agonisteina
JP2016528245A5 (enExample)
CA2959757A1 (en) Pyrazole derivatives as sgc stimulators
JP2011521911A5 (enExample)
CA3071760A1 (en) Combination of atr kinase inhibitors and pd-1/pd-l1 inhibitors
MX2012004848A (es) Compuestos heterociclicos triciclicos.
JP2014526500A5 (enExample)
JP2013522165A5 (enExample)
NZ588830A (en) Inhibitors of protein kinases
JP2014511891A5 (enExample)
JP2017528487A5 (enExample)
JP2016506961A5 (enExample)
JP2016505637A5 (enExample)
PE20141167A1 (es) Piridopirazinas sustituidas como inhibidores novedosos de ptk
AR066701A1 (es) 3-( imidazolil)- pirazolo {3,4-b] piridinas, composicion farmaceutica, proceso y uso en terapia
MX2009013501A (es) Compuestos piperidinicos y sus usos.
JP2015509075A5 (enExample)
UA107353C2 (en) Salts of bicyclo-substituted pyrazolon azo derivatives, preparation method and use thereof
CY1123346T1 (el) Παραγωγα 5-[2-(πυριδιν-2-υλαμινο)-1,3-θειαζολ-5-υλ]-2,3-διυδρο-1η-ισοϊνδολ-1-ονης και χρηση τους ως διπλοι αναστολεις της 3-κινασης φωσφατιδυλοϊνοσιτολης δελτα & γαμμα